F

Faes Farma, S.A.

BME-FAE
Madrid Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#6881
Country Rank
#57
Market Cap
$1.63 B
Price
$5.25
Change (%)
0.22%
Volume
208,700

BME-FAE's Next Dividend

Next Estimated Amount
€0.00889
Next Estimated Pay Date
07/21/2025
Last Amount
€0.0332
Last Pay Date
01/13/2025
Dividend Shot Clock Ex-Date: 01/09/2025
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Faes Farma, S.A. Dividend Chart

*Amounts are shown in the stock exchange currency (EUR) for convenience

Faes Farma, S.A.(BME-FAE) Dividend History

Faes Farma, S.A. (BME-FAE) currently pays an annual dividend of $0.13 per share, offering a dividend yield of 3.48%. The next dividend payout date has not been announced.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2025 €0.0332 -74%
01/09/2025 €0.0332 01/10/2025 01/13/2025 -65%
2024 €0.126 -15%
07/04/2024 €0.094 07/05/2024 07/08/2024 197%
01/11/2024 €0.0316 01/12/2024 01/15/2024 -73%
2023 €0.148 421%
04/12/2023 €0.118 04/13/2023 04/19/2023 293%
01/05/2023 €0.03 01/06/2023 01/09/2023 6%
2022 €0.0284 -83%
06/28/2022 €0.0284 06/29/2022 06/30/2022 -79%
2021 €0.163 4%
12/16/2021 €0.138 12/17/2021 12/23/2021 470%
06/23/2021 €0.0243 06/24/2021 06/25/2021 -82%
2020 €0.156
12/16/2020 €0.135 12/17/2020 12/23/2020 541%
06/30/2020 €0.0211 07/01/2020 07/02/2020
*Amounts are shown in the stock exchange currency (EUR) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.